Non-bacteremic pneumococcal pneumonia: general characteristics and early predictive factors for poor outcome

References

• Ardanuy C, Tubau F, Pallarés R, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction 1997–2007. Clin Infect Dis. 2009;48(1):57–64.
   PubMed Web of Science ®Google Scholar
• Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543–1556.
   PubMed Web of Science ®Google Scholar
• Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50(2):202–209.
   PubMed Web of Science ®Google Scholar
• Shariatzadeh MR, Huang JQ, Tyrrell GJ, et al. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore). 2005;84(3):147–161.
   PubMed Web of Science ®Google Scholar
• Rosón B, Carratalà J, Dorca J, et al. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria . Clin Infect Dis. 2001;33(2):158–165.
   PubMed Web of Science ®Google Scholar
• Smith MD, Derrington P, Evans R, et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003;41(7):2810–2813.
   PubMed Web of Science ®Google Scholar
• Sinclair A, Xie X, Teltscher M, et al. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol. 2013;51(7):2303–2310.
   PubMed Web of Science ®Google Scholar
• Domínguez J, Galí N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest. 2001;119(1):243–249.
   PubMed Web of Science ®Google Scholar
• Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J. 2003;21(2):209–214.
   PubMed Web of Science ®Google Scholar
• Ceccato A, Torres A, Cilloniz C, et al. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia. Chest. 2017;151(6):1311–1319.
   PubMed Web of Science ®Google Scholar
• Watanakunakom C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992–1996: a detailed analysis of 108 cases. Arch Intern Med. 1997;157(17):1965–1971.
   PubMedGoogle Scholar
• Watanakunakorn C, Greifenstein A, Stroh K, et al. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest. 1993;103(4):1152–1156.
   PubMed Web of Science ®Google Scholar
• Torres JM, Cardenas O, Vasquez A, et al. Streptococcus pneumoniae bacteremia in a community hospital. Chest. 1998;113(2):387–390.
   PubMed Web of Science ®Google Scholar
• Mufson MA, Kruss DM, Wasil RE, et al. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med. 1974;134(3):505–510.
   PubMedGoogle Scholar
• Song JH, Jung SI, Ki HK, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004;38(11):1570–1578.
   PubMed Web of Science ®Google Scholar
• Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37(2):230–237.
   PubMed Web of Science ®Google Scholar
• Moroney JF, Fiore AE, Harrison LH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis. 2001;33(6):797–805.
   PubMed Web of Science ®Google Scholar
• Capelastegui A, Zalacain R, Bilbao A, et al. Pneumococcal pneumonia: differences according to blood culture results. BMC Pulm Med. 2014;14(1):128.
   PubMedGoogle Scholar
• Musher DN, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore). 2000;79(4):210–221.
   PubMed Web of Science ®Google Scholar
• Palma I, Mosquera R, Demier C, et al. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia. J Bras Pneumol. 2012;38(4):422–430.
   PubMed Web of Science ®Google Scholar
• Jover F, Cuadrado JM, Andreu L, et al. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med. 2008;19(1):15–21.
   PubMed Web of Science ®Google Scholar
• Amaro R, Liapikou A, Cilloniz C, et al. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia. Eur Respir J. 2016;48(3):797–807.
   PubMed Web of Science ®Google Scholar
• Bordon JM, Fernandez-Botran R, Wiemken TL, et al. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response. Infection. 2015;43(6):729–738.
   PubMed Web of Science ®Google Scholar
• Lin SH, Lai CC, Tan CK, et al. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect. 2011;139(9):1307–1316.
   PubMed Web of Science ®Google Scholar
• Ishiguro T, Kagiyama N, Uozumi R, et al. Risk factors for the severity and mortality of pneumococcal pneumonia: importance of premorbid patients’ performance status. J Infect Chemother. 2016;22(10):685–691.
   PubMed Web of Science ®Google Scholar
• España PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174(11):1249–1256.
   PubMed Web of Science ®Google Scholar
• Alfageme I, Aspa J, Bello S, et al. Normativa para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Arch Bronconeumol. 2005;41(5):272–289.
   PubMedGoogle Scholar
• Menéndez R, Torres A, Aspa J, et al. [Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)]. Arch Bronconeumol. 2010;46(10):543–558.
   PubMed Web of Science ®Google Scholar
• Lim WS, Van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) Cohort Study. Arch Intern Med. 1999;159(9):970–980.
   PubMedGoogle Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS: SCCM/ESICM/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530–538.
   PubMedGoogle Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
   PubMed Web of Science ®Google Scholar
• Menéndez R, Torres A, Zalacaín R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59(11):960–965.
   PubMed Web of Science ®Google Scholar
• Klein Klouwenberg PMC, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study. Am J Respir Crit Care Med. 2017;195(2):205–211.
   PubMed Web of Science ®Google Scholar
• Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: CRC Press; 1994.
   Google Scholar
• R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria 2019; [cited 2020 May 21]. Available from: https://www.R-project.org/.
   Google Scholar
• Frank E., Harrell   Jr. rms: Regression Modeling Strategies. R package version 5.1-4 2019 ; [cited 2020 May 21]. Available from: https://CRAN.R-project.org/package=rms.
   Google Scholar
• Molinos L, Zalacain R, Menéndez R, et al. Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia. Ann Am Thoracic Soc. 2015;12(10):1482–1489.
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, et al. Active bacterial core surveillance of the emerging infections program network. decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737–1746.
   PubMed Web of Science ®Google Scholar
• Gattarello S, Borgatta B, Solé-Violán J, et al. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000–2013). Chest. 2014;146(1):22–31.
   PubMed Web of Science ®Google Scholar
• Van Mens SP, Van Deursen AMM, De Greeff SC, et al. Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared. Eur J Clin Microbiol Infect Dis. 2015;34(1):115–122.
   PubMed Web of Science ®Google Scholar
• Burillo A, Pedro-Botet ML, Bouza E. Microbiology and epidemiology of legionnaire’s disease. Infect Dis Clin North Am. 2017;31(1):7–27.
   PubMed Web of Science ®Google Scholar
• Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus Community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis. 2016;63(3):300–309.
   PubMed Web of Science ®Google Scholar
• Ruiz LA, Gómez A, Jaca C, et al. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection. 2010;38(6):453–458.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement_2):S27–S72.
   PubMed Web of Science ®Google Scholar
• Hanada S, Iwata S, Kishi K, et al. Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease. PLoS One. 2016;11(1):e0147877.
   PubMed Web of Science ®Google Scholar
• Kim JW, Kim JJ, Yang HJ, et al. The prognostic factors of pneumonia with septic shock in patients presenting to the emergency department. Korean J Crit Care Med. 2015;30(4):258–264.
   Google Scholar
• Morley D, Torres A, Cilloniz C, et al. Predictors of treatment failure and clinical stability in patients with community acquired pneumonia. Ann Transl Med. 2017;5(22):443.
   PubMed Web of Science ®Google Scholar
• Quinton LJ, Walkey AJ, Mizgerd JP. Integrative Physiology of Pneumonia. Physiol Rev. 2018;98(3):1417–1464.
   PubMed Web of Science ®Google Scholar
• Delano MJ, Ward PA. The Immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330–353.
   PubMed Web of Science ®Google Scholar
• Musher DM, Rueda-Jaimes AM, Graviss EA, et al. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis. 2006;43(8):1004–1008.
   PubMed Web of Science ®Google Scholar
• Dear K, Holden J, Andrews R, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2003;4:CD000422.
   Google Scholar
• Payeras A, Peñaranda M, Iñigo A, et al. Pneumococcal infections in elderly patients attending hospital since PCV-13 authorization in Spain. Infect Dis (Lond). 2017;49(1):71–80.
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–1125.
   PubMed Web of Science ®Google Scholar